Trinity Biotech reported $10.85M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Bayer EUR 10.05B 820M Sep/2026
Bio-Rad Laboratories USD 656.4M 5.4M Sep/2026
EDAP TMS EUR 15.42M 1.54M Mar/2026
J&J USD 25.4B 89M Sep/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.03M 339K Mar/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Siemens EUR 23.68B 2.89B Sep/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Tosoh JPY 305.5B 31.33B Sep/2026
Trinity Biotech USD 10.85M 226K Mar/2026
Veracyte USD 151.75M 1.43M Sep/2026